Different Th17 immunity in gut, liver, and adipose tissues during obesity: the role of diet, genetics, and microbes

Gut Microbes

Volumn 7, Issue 1, 2016, Pages 82-89

  Cavallari, Joseph F ^a   Denou, Emmanuel ^a   Foley, Kevin P ^a   Khan, Waliul I ^a,b   Schertzer, Jonathan D ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

diabetes; glucose; high fat diet; immunometabolism; insulin resistance; metabolic endotoxemia; microbiota; peptidoglycan

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 31; INTERLEUKIN 33; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; CARD15 PROTEIN, MOUSE; CYTOKINE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON; CONTROLLED STUDY; GENE DELETION; GENETICS; ILEUM; IMMUNE RESPONSE; INTESTINE; LEUKOCYTE ACTIVATION; LIPID DIET; LIVER; MICROORGANISM; MOUSE; NONHUMAN; OBESITY; TH17 CELL; ANIMAL; C57BL MOUSE; DEFICIENCY; GASTROINTESTINAL TRACT; IMMUNOLOGY; INTESTINE FLORA; MALE; MICROBIOLOGY; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY;

ADIPOSE TISSUE; ANIMALS; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; LIVER; MALE; MICE; MICE, INBRED C57BL; NEUTROPHIL ACTIVATION; NEUTROPHILS; NOD2 SIGNALING ADAPTOR PROTEIN; OBESITY; TH17 CELLS;

EID: 84960339304     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2015.1127481     Document Type: Article

References (39)

1. M.F.Gregor, G.S.Hotamisligil. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011; 29:415-45; PMID:21219177; http://dx.doi.org/10.1146/annurev-immunol-031210-101322
2. J.D.Schertzer, G.R.Steinberg. Immunometabolism: the interface of immune and metabolic responses in disease. Immunol Cell Biol 2014; 92:303; PMID:24613974; http://dx.doi.org/10.1038/icb.2014.12
3. G.R.Steinberg, J.D.Schertzer. AMPK promotes macrophage fatty acid oxidative metabolism to mitigate inflammation: implications for diabetes and cardiovascular disease. Immunol Cell Biol 2014; 92:340-5; PMID:24638063; http://dx.doi.org/10.1038/icb.2014.11
4. M.D.Fullerton, G.R.Steinberg, J.D.Schertzer. Immunometabolism of AMPK in insulin resistance and atherosclerosis. Mol Cell Endocrinol 2013; 366:224-34; PMID:22361321; http://dx.doi.org/10.1016/j.mce.2012.02.004
5. P.D.Cani, M.Osto, L.Geurts, A.Everard. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012; 3:279-88; PMID:22572877; http://dx.doi.org/10.4161/gmic.19625
6. R.Burcelin, M.Serino, C.Chabo, L.Garidou, C.Pomié, M.Courtney, J.Amar, A.Bouloumié. Metagenome and metabolism: The tissue microbiota hypothesis. Diabetes, Obes. Metab. 2013; 15:61-70
7. P.D.Cani, J.Amar, M.A.Iglesias, M.Poggi, C.Knauf, D.Bastelica, A.M.Neyrinck, F.Fava, K.M.Tuohy, C.Chabo, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56:1761-72; PMID:17456850; http://dx.doi.org/10.2337/db06-1491
8. P.D.Cani, R.Bibiloni, C.Knauf, A.Waget, A.M.Neyrinck, N.M.Delzenne, R.Burcelin. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57:1470-81; PMID:18305141; http://dx.doi.org/10.2337/db07-1403
9. A.K.Tamrakar, J.D.Schertzer, T.T.Chiu, K.P.Foley, P.J.Bilan, D.J.Philpott, A.Klip. NOD2 activation induces muscle cell-autonomous innate immune responses and insulin resistance. Endocrinology 2010; 151:5624-37; PMID:20926588; http://dx.doi.org/10.1210/en.2010-0437
10. J.D.Schertzer, A.K.Tamrakar, J.G.Magalhães, S.Pereira, P.J.Bilan, M.D.Fullerton, Z.Liu, G.R.Steinberg, A.Giacca, D.J.Philpott, et al. NOD1 activators link innate immunity to insulin resistance. Diabetes 2011; 60:2206-15; PMID:21715553; http://dx.doi.org/10.2337/db11-0004
11. W.Chi, D.Dao, T.C.Lau, B.D.Henriksbo, J.F.Cavallari, K.P.Foley, J.D.Schertzer. Bacterial Peptidoglycan Stimulates Adipocyte Lipolysis via NOD1. PLoS One 2014; 9:e97675; PMID:24828250; http://dx.doi.org/10.1371/journal.pone.0097675
12. B.D.Henriksbo, T.C.Lau, J.F.Cavallari, E.Denou, W.Chi, J.S.Lally, J.D.Crane, B.M.Duggan, K.P.Foley, M.D.Fullerton, et al. Fluvastatin Causes NLRP3 Inflammasome-Mediated Adipose Insulin Resistance. Diabetes 2014; 63:3742-7; PMID:24917577; http://dx.doi.org/10.2337/db13-1398
13. H.Shi, M.V.Kokoeva, K.Inouye, I.Tzameli, H.Yin, J.S.Flier. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116:3015-25; PMID:17053832; http://dx.doi.org/10.1172/JCI28898
14. T.Nakamura, R.C.Kunz, C.Zhang, T.Kimura, C.L.Yuan, B.Baccaro, Y.Namiki, S.P.Gygi, G.S.Hotamisligil. A Critical Role for PKR Complexes with TRBP in Immunometabolic Regulation and eIF2α Phosphorylation in Obesity. Cell Rep 2015; 11(2):295-307; PMID:25843719; http://dx.doi.org/10.1016/j.celrep.2015.03.021
15. B.Vandanmagsar, Y.-H.Youm, A.Ravussin, J.E.Galgani, K.Stadler, R.L.Mynatt, E.Ravussin, J.M.Stephens, V.D.Dixit. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 2011; 17:179-88; PMID:21217695; http://dx.doi.org/10.1038/nm.2279
16. M.Poggi, D.Bastelica, P.Gual, M.A.Iglesias, T.Gremeaux, C.Knauf, F.Peiretti, M.Verdier, I.Juhan-Vague, J.F.Tanti, et al. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 2007; 50:1267-76; PMID:17426960; http://dx.doi.org/10.1007/s00125-007-0654-8
17. E.Denou, K.Lolmede, L.Garidou, C.Pomie, C.Chabo, T.C.Lau, M.D.Fullerton, G.Nigro, A.Zakaroff-Girard, E.Luche, et al. Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance. EMBO Mol Med 2015; 7:259-74; PMID:25666722; http://dx.doi.org/10.15252/emmm.201404169
18. A.M.Caricilli, P.K.Picardi, L.L.de Abreu, M.Ueno, P.O.Prada, E.R.Ropelle, S.M.Hirabara, Â.Castoldi, P.Vieira, N.O.S.Camara, et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol 2011; 9; e1001212; PMID:22162948
19. A.Couturier-Maillard, T.Secher, A.Rehman, S.Normand, De A.Arcangelis, R.Haesler, L.Huot, T.Grandjean, A.Bressenot, A.Delanoye-Crespin, et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest 2013; 123(2):700-11; PMID:23281400; http://dx.doi.org/10.1172/JCI62236
20. M.D.Schulz, C.Atay, J.Heringer, F.K.Romrig, S.Schwitalla, B.Aydin, P.K.Ziegler, J.Varga, W.Reindl, C.Pommerenke, et al. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature 2014; 514(7523):508-12; PMID: 25174708
21. P.J.Turnbaugh, V.K.Ridaura, J.J.Faith, F.E.Rey, R.Knight, J.I.Gordon. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009; 1:6ra14; PMID:20368178
22. V.K.Ridaura, J.J.Faith, F.E.Rey, J.Cheng, A.E.Duncan, A.L.Kau, N.W.Griffin, V.Lombard, B.Henrissat, J.R.Bain, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341:1241214; PMID:24009397; http://dx.doi.org/10.1126/science.1241214
23. Y.Ogura, D.K.Bonen, N.Inohara, D.L.Nicolae, F.F.Chen, R.Ramos, H.Britton, T.Moran, R.Karaliuskas, R.H.Duerr, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411:603-6; PMID:11385577; http://dx.doi.org/10.1038/35079114
24. F.Barreau, C.Madre, U.Meinzer, D.Berrebi, M.Dussaillant, F.Merlin, L.Eckmann, M.Karin, G.Sterkers, S.Bonacorsi, et al. Nod2 regulates the host response towards microflora by modulating T cell function and epithelial permeability in mouse Peyer's patches. Gut 2010; 59:207-17; PMID:19837677; http://dx.doi.org/10.1136/gut.2008.171546
25. A.J.van Beelen, Z.Zelinkova, E.W.Taanman-Kueter, F.J.Muller, D.W.Hommes, S.Zaat a J, M.L.Kapsenberg, E.C.de Jong. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 2007; 27:660-9; PMID:17919942; http://dx.doi.org/10.1016/j.immuni.2007.08.013
26. K.Geddes, S.J.Rubino, J.G.Magalhaes, C.Streutker, L.Le Bourhis, J.H.Cho, S.J.Robertson, C.J.Kim, R.Kaul, D.J.Philpott, et al. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat Med 2011; 17:837-44; PMID:21666695; http://dx.doi.org/10.1038/nm.2391
27. E.Bettelli, T.Korn, M.Oukka, V.K.Kuchroo. Induction and effector functions of T(H)17 cells. Nature 2008; 453:1051-7; PMID:18563156; http://dx.doi.org/10.1038/nature07036
28. W.Ouyang, J.K.Kolls, Y.Zheng. The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation. Immunity 2008; 28:454-67; PMID:18400188; http://dx.doi.org/10.1016/j.immuni.2008.03.004
29. X.Wang, N.Ota, P.Manzanillo, L.Kates, J.Zavala-Solorio, C.Eidenschenk, J.Zhang, J.Lesch, W.P.Lee, J.Ross, et al. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 2014; 514:237-41; PMID:25119041
30. L.Garidou, C.Pomié, P.Klopp, A.Waget, J.Charpentier, M.Aloulou, A.Giry, M.Serino, L.Stenman, S.Lahtinen, et al. The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORγt and Controls Metabolic Disease. Cell Metab 2015; 22:100-12; PMID:26154056; http://dx.doi.org/10.1016/j.cmet.2015.06.001
31. S.Winer, G.Paltser, Y.Chan, H.Tsui, E.Engleman, D.Winer, H.M.Dosch. Obesity predisposes to Th17 bias. Eur J Immunol 2009; 39:2629-35; PMID:19662632; http://dx.doi.org/10.1002/eji.200838893
32. S.Ding, M.M.Chi, B.P.Scull, R.Rigby, N.M.J.Schwerbrock, S.Magness, C.Jobin, P.K.Lund. High-fat diet: Bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 2010; 5: e12191; PMID: 20808947
33. A.M.F.Johnson, A.Costanzo, M.G.Gareau, A.M.Armando, O.Quehenberger, J.M.Jameson, J.M.Olefsky. High Fat Diet Causes Depletion of Intestinal Eosinophils Associated with Intestinal Permeability. PLoS One 2015; 10:e0122195; PMID:25837594; http://dx.doi.org/10.1371/journal.pone.0122195
34. C.L.Zindl, J.-F.Lai, Y.K.Lee, C.L.Maynard, S.N.Harbour, W.Ouyang, D.D.Chaplin, C.T.Weaver. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci U S A 2013; 110:12768-73; PMID:23781104; http://dx.doi.org/10.1073/pnas.1300318110
35. B.M.Fournier, C.A.Parkos. The role of neutrophils during intestinal inflammation. Mucosal Immunol 2012; 5:354-66; PMID:22491176; http://dx.doi.org/10.1038/mi.2012.24
36. S.Talukdar, D.Y.Oh, G.Bandyopadhyay, D.Li, J.Xu, J.McNelis, M.Lu, P.Li, Q.Yan, Y.Zhu, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med 2012; 18:1407-12; PMID:22863787; http://dx.doi.org/10.1038/nm.2885
37. A.M.Lin, C.J.Rubin, R.Khandpur, J.Y.Wang, M.Riblett, S.Yalavarthi, E.C.Villanueva, P.Shah, M.J.Kaplan, A.T.Bruce. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 2011; 187:490-500; PMID:21606249; http://dx.doi.org/10.4049/jimmunol.1100123
38. J.B.McPhee, J.D.Schertzer. Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation. Clin Sci 2015; 129:1083-96; PMID:26464517; http://dx.doi.org/10.1042/CS20150431
39. J.J.Kim, M.S.Shajib, M.M.Manocha, W.I.Khan. Investigating Intestinal Inflammation in DSS-induced Model of IBD. J Vis Exp 2012; 60; PMID: 22331082